Transcat, Inc. · NASDAQ:TRNS
Transcat — Investor Presentation (June 2026)
29 slides from Transcat's investor presentation, June 2026
Slide 1: Leader in Test, Measurement, Control & Calibration
NASDAQ: TRNS Leader in Test, Measurement, Control & Calibration INVESTOR PRESENTATION June 2026
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than historical fact are forward-looking statements. Forward-looking statements are not statements of historical fact and thus
Slide 3: Corporate Overview & Strategy
Corporate Overview & Strategy Transcat is an industry leading provider of mission critical, accredited calibration services and equipment, and the only public company of its kind. Highly fragmented, large market opportunity highlights NASDAQ: TRNS path to $500M revenue and top-tier margins in 3-5 ye
Slide 4: Company Overview
Company Overview Industry leading provider of mission critical, accredited calibration services and equipment FOUNDED IN 1964 NASDAQ:TRNS DISTRIBUTOR AND FOOTPRINT 35 COMMERCIAL 68 CONSECUTIVE TRANSCAT NEXA COST, OVER 61 YEARS PUBLICLY-TRADED RENTAL OF TEST AND SCALE TO LABS QUARTERS OF YOY UNIVERSI
Slide 5: Compelling Equity Story with Multiple Growth Drivers
Compelling Equity Story with Multiple Growth Drivers Calibration and Instrumentation Services Sector Fragmented and Localized Attractive & Growing Regulatory Driven Model Recurring Revenue Model Growing TAM Decision Makers End Markets Highly fragmented industry, with In addition to regulatory driven
Slide 6: Transcat's Revenue Mix Evolution
Transcat’s Revenue Mix Evolution Transforming the revenue landscape with a deliberate shift toward the recurring service segment Jaime Irick, Michael West, Thomas Barbato, President & CEO Chief Operating Officer Chief Financial Officer Appointed March 2026 Appointed April 2024 Appointed Sept 2022 12
Slide 7: All Roads Lead to Service
All Roads Lead to Service Acquires SCM Metrology and Laboratories S.A. GM% 68 Consecutive Quarters of YOY Cal i br a t S e r v i c ion Service Revenue Growth Acquires Martin Calibration & 35% es Essco Calibration Laboratory tion a 275,000 Axiom r Accelerating Rental Growth ne Pr Ge im Strong Cross-S
Slide 8: Complementary Business Segments
Complementary Business Segments Strong cross-selling opportunities from distribution to calibration services OPPORTUNITY FOR ACCELERATED GROWTH AND MARGIN EXPANSION nu e ws Su e Pr Flo pp ev i sh m R or a ar g gC ts rin yG Gro S t r on Recur r ow t h D r i v e r wth S trateg Calibration Services Dis
Slide 9: Strategic, Regulated Vertical Markets
Strategic, Regulated Vertical Markets • Provider of premium, mission critical services to regulated, high cost of failure industries that require long qualification cycles • High switching costs deeply entrench customers on Transcat service platform; high barrier to entry that results in recurring,
Slide 10: International Footprint & Strategy
International Footprint & Strategy 50+ Locations & Mobile Serving U.S., Canada, Ireland & Latin America – Strong Competitive Advantage Flexible Service Delivery Options : ✓ Client-Based Lab ✓ Periodic On-Site ✓ Mobile ✓ In-House ✓ Pickup & Delivery Map Legend Transcat Headquarters Transcat Calibrati
Slide 11: Broad and Diverse Blue-Chip Customer Base
Broad and Diverse Blue-Chip Customer Base Servicing the Fortune 500 Manufacturers • Pharmaceuticals Percentage of Service Revenue 1 • Medical Devices o Orthopedics o Endoscopy Life Science / Industrials / FDA Regulated, o Surgical Tools Materials, 16% 60% • Defense Systems • Aerospace • Uranium Proc
Slide 12: Recent Acquisition Drivers
Recent Acquisition Drivers Increased Capabilities Leveraged Infrastructure Year Target Geographic Expansion & Expertise (Bolt-on) FY26 FY25 FY25 FY24 FY24 FY24 FY24 FY23 FY22 FY22 FY22 FY21 FY21 * Company estimates based on FY 2025 12
Slide 13: Acquisition & Integration Strategy
Acquisition & Integration Strategy Proven Process Drives Consistent Long-Term Value Capture and Returns Diligence & Decision Making Martin Calibration – Case Study • Disciplined approach with high emphasis on cultural fit Expanding Presence in Upper Midwest • Strategic checklist and consistent asses
Slide 14: Essco Calibration Laboratory
Essco Calibration Laboratory New England Market Leader in Calibration Services ✓ Largest deal in Transcat history - $84 million cash purchase – August 2025 ✓ Transaction was supported by new $150 million syndicated credit facility jointly led by M&T Bank and Wells Fargo Bank ✓ Operating for over 50
Slide 15: SCM Metrology & Laboratories S.A.
SCM Metrology & Laboratories S.A. Opportunity-Rich Latin American Market with Strategically Aligned Customers ✓ $13 million cash purchase – April 2026 ✓ First operational presence in Latin America, advancing the strategy to grow alongside customers in high-growth, highly regulated end markets ✓ Oper
Slide 16: Q4 FY26 and Full Year FY26 Summary
Q4 FY26 and Full Year FY26 Summary • Q4 Revenue grew 16% vs prior year to $89.3M; full year Revenue grew 19% to $331.9M • Adjusted EBITDA* increased 16% from prior year to $14.8M in Q4; full year Adjusted Consolidated Results EBITDA* of $48.7M up 23% • Full year Net Income of $5.4M or $0.57 per dilu
Slide 17: Outlook
Outlook* 2027 Expectations Service segment: We expect service organic revenue growth to continue in the high single digits in Fiscal 2027, assuming the broader economic environment remains stable Total Transcat: We expect the fiscal 2027 income tax rate to be in the range of 31%-33%. Mid-to-long Ter
Slide 18: Summary
Summary • 62 years experience across complementary Calibration Services and Distribution/Rental segments • Market opportunity in expanding, highly regulated, high cost of failure, and mission critical industries including Life Sciences, Aerospace and Government/Defense • Service segment is a growth
Slide 19: Investor Relations
NASDAQ: TRNS Investor Relations Chris Tyson Executive Vice President MZ Group - MZ North America 949-491-8235 TRNS@mzgroup.us TRANSCAT, INC transcat.com transcat.com 35 Vantage Point Drive Rochester, NY 14624
Slide 20: Financial Overview
Financial Overview
Slide 21: Revenue
Revenue ($ in millions) Service Segment Distribution Segment Consolidated $62.5 $27.8 $89.3 $25.1 $52.0 11% $77.1 18% 16% Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 • Consolidated revenue up Q4 15.8% and FY 19.2%, with both Full Year Consolidated segments delivering double-digit growth $331.9 •
Slide 22: Gross Profit and Margin
Gross Profit and Margin ($ in millions) Service Segment Distribution Segment Consolidated $21.9 $8.6 $30.5 16% 22% 18% $18.8 $7.1 $25.9 36.2% 35.5% 28.2% 31.0% 33.6% 34.1% Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 • Consolidated gross profit of $30.5M for Q4 increased 18% Full Year Consolidate
Slide 23: Net Income, Diluted EPS, Adjusted Diluted EPS
Net Income, Diluted EPS, Adjusted Diluted EPS* ($ in millions, except EPS) Net Income Diluted EPS Adjusted Diluted EPS* $4.5 $0.64 (13%) (58%) $0.48 (56%) $0.56 $1.9 $0.21 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Full Year Net Income • Q4 adjusted diluted EPS of $0.56 vs $0.64 prior year $14.
Slide 24: Adjusted Operating Income, EBITDA and Margin
Adjusted Operating Income*, EBITDA* and Margin ($ in millions) Service Adjusted Distribution Adjusted Consolidated Adjusted Operating Income* Operating Income* EBITDA* $11.2 $14.8 $10.3 $3.7 9% 42% $12.7 16% $2.6 19.8% 18.2% 10.4% 13.4% 16.5% 16.6% Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Ful
Slide 25: Operating Free Cash Flow
Operating Free Cash Flow ($ in millions) Fiscal Year Ended Note: Components may not add to totals March 28, 2026 March 29, 2025 • Operating Free Cash Flow** of $19.6M for due to rounding FY26 reflects working capital investment supporting strong revenue growth Net cash provided by operations $34.9 $
Slide 26: Balance Sheet Supports Growth Strategy
Balance Sheet Supports Growth Strategy ($ in millions) Capitalization Note: Components may not add to totals due to rounding March 28, 2026 March 29, 2025 Cash & Cash Equivalents $4.9 $1.5 • 2.03x leverage ratio at quarter-end (Total debt to TTM Adjusted Total Debt $99.9 $32.7 EBITDA*) Total net deb
Slide 27: Supplemental Information
Supplemental Information
Slide 28: Adjusted EBITDA and Operating Income Reconciliation
Adjusted EBITDA and Operating Income Reconciliation ($ in thousands) FY 2026 Q4 FY 2025 Q4 Net Income (Loss) $ 1,947 $ 4,464 ($ in thousands) + Interest Expense / (Income), net 1,375 463 + Tax (Benefit) Provision 887 1,792 + Depreciation & Amortization 6,950 5,625 + Executive Transition Costs 935 -
Slide 29: Adjusted Diluted EPS Reconciliation
Adjusted Diluted EPS Reconciliation ($ in thousands) ($ in thousands except per share data) FY 26 Q4 FY 25 Q4 GAAP Net Income $ 1,947 $ 4,464 Add back (deduct) $ 3,290 $ 1,475 Amortization of Intangibles 3,488 2,906 Acquisition deal costs 175 34 Acq Stock Expense 290 141 Executive Transition Costs 9